Abstracts | 59 receptors consisting of various α subunits, including the α6 subunit (α6GABA A R) that mainly exists in cerebellar granule cells. We therefore examined whether cerebellar α6GABA A Rs play a role in PPI impairment, a measurement reflecting sensorimotor gating deficit manifested in patients with several neuropsychiatric disorders, including TS and schizophrenia. PPI impairment in mice was induced by MA (a dopamine releaser) and NMDA channel blockers (ketamine, MK-801 and phencyclidine), respectively, based on hyper-dopaminergic and hypo-glutamatergic hypotheses of schizophrenia. Hispidulin given by either i.p (10-30 mg/kg) or intracerebellar (i.c.b., 10 nmol) injection, significantly rescued PPI impairments induced by both MA and NMDA channel blockers. 
Abstracts | 59 receptors consisting of various α subunits, including the α6 subunit (α6GABA A R) that mainly exists in cerebellar granule cells. We therefore examined whether cerebellar α6GABA A Rs play a role in PPI impairment, a measurement reflecting sensorimotor gating deficit manifested in patients with several neuropsychiatric disorders, including TS and schizophrenia. PPI impairment in mice was induced by MA (a dopamine releaser) and NMDA channel blockers (ketamine, MK-801 and phencyclidine), respectively, based on hyper-dopaminergic and hypo-glutamatergic hypotheses of schizophrenia. Hispidulin given by either i.p (10-30 mg/kg) or intracerebellar (i.c.b., 10 nmol) injection, significantly rescued PPI impairments induced by both MA and NMDA channel blockers. , also effectively rescued MA-induced PPI impairment and this effect was prevented by i.c.b. furosemide. These results suggest that the cerebellar α 6 -GABA A R is a novel target for PPI impairment, and selective α 6 -GABA A R PAMs have the potential for treating neuropsychiatric disorders with sensorimotor gating deficit, such as schizophrenia, TS, obsessive-compulsive disorder and attention deficit hyperactivity disorder.
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Spatial and temporal modulation of Homer1a gene expression at the post-synaptic density is related to D2R affinity and dose of antipsychotics: translational considerations for schizophrenia treatment strategies. Abstract Background: Homer1a is an immediate-early-gene of the glutamatergic post-synaptic density (PSD), involved in synaptic plasticity and whose expression is elicited by antipsychotics (APDs). Here we provide a comparative analysis of Homer1a expression data by multiple first and second-generation APDs, in order to classify their impact on PSD and correlate it to their receptor profile. Methods: we collected data from multiple In Situ Hybridization experiments carried out in our laboratory in standard controlled conditions, analysing Homer1a induction by APDs in Sprague-Dawley rat forebrain. Homer1a expression levels were normalized as the ratio of the corresponding mean vehicle value in each subregion. Normalized expression levels were quantitatively compared by ANOVA and Tukey's post-hoc test (p<.05), and then grouped in four classes: no induction; light induction; moderate induction; high induction. Results: In the cortex, Homer1a mRNA was not induced by sertindole, 4mg/kg ziprasidone, haloperidol (0.25 and 0.5mg/kg). Haloperidol 0.8mg/kg, 15mg/kg quetiapine, 10mg/kg and 35mg/ kg amisulpride triggered light induction. Moderate induction was found for 30mg/kg quetiapine, olanzapine, clozapine, 10mg/ kg ziprasidone and for asenapine at all doses tested. Notably, both clozapine and 10mg/kg ziprasidone induced the highest levels of Homer1a mRNA in the insular cortex.
In the striatum, sertindole did not induce Homer1a expression. Quetiapine and amisulpride were observed to trigger light induction of the gene. Clozapine triggered a light-moderate induction. Moderate induction was found by olanzapine and aripiprazole, while high induction was found by ziprasidone, asenapine, and haloperidol, especially in caudate-putamen regions.
A strong correlation with D2 receptor blockade and the extent of Homer1a expression in striatum, but not in the cortex, was found. Conclusions: Homer1a expression levels throughout APDs were dose-dependent and under a major D2 receptor-dependent control. However, other molecular mechanisms (e.g. D1 receptor activation in striatum; 5-HT2A receptor blockade in the cortex) may contribute to affect its expression levels.
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Functional connectivity and striatal dopamine synthesis in schizophrenia treated with antipsychotic drugs: multimodal imaging study using 
Abstract
All the antipsychotic drugs currently available are acting on the postsynaptic dopamine receptors and the antipsychotic drugs may exert antipsychotic effect by blocking the receptor and reducing the elevated dopaminergic neurotransmission from presynaptic to postsynaptic area. However, all the antipsychotic drugs with the same mechanism of action are not all the same in the aspects of clinical efficacy. For example, clozapine shares its pharmacological characteristics with other antipsychotic drugs as a dopamine blocker. However, clozapine is the only antipsychotic drug with proven efficacy in refractory patients with schizophrenia. This could be associated with the unique pharmacological characteristics of clozapine that affects glutamatergic system, interacting with dopamine system in a co-modulatory manner. Furthermore, clozapine seems to affect functional connectivity between the frontal lobe and the striatum in a different manner influencing presynaptic dopamine synthesis.
In the present study, we sought to evaluate the antipsychotic effect on functional connectivity and presynaptic dopamine capacity and compare the effect between first-line antipsychotic drugs and clozapine.
